Kiniksa accounting chief exercises options, sells shares
Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash
Kiniksa Pharmaceuticals International Chief Accounting Officer Michael R. Megna exercised options on 19,895 shares and sold 36,260 Class A Ordinary Shares under a Rule 10b5-1 trading plan. Sales carried weighted average prices between $91.87 and $97.74. He directly holds 12,697 Class A shares and retains unexercised options. The sale is a pre-scheduled insider transaction, not a change in company fundamentals.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.